Development of mitochondria-targeted derivatives of resveratrol

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5594-7. doi: 10.1016/j.bmcl.2008.08.100. Epub 2008 Aug 31.

Abstract

To target natural polyphenols to the subcellular site where their redox properties might be exploited at best, that is, mitochondria, we have synthesised new proof-of-principle derivatives by linking resveratrol (3,4',5-trihydroxy-trans-stilbene) to the membrane-permeable lipophilic triphenylphosphonium cation. The new compounds, (4-triphenylphosphoniumbutyl)-4'-O-resveratrol iodide and its bis-acetylated derivative, the latter intended to provide transient protection against metabolic conjugation, accumulate into energized mitochondria as expected and are cytotoxic for fast-growing but not for slower-growing cells. They provide a powerful potential tool to intervene on mitochondrial and cellular redox processes of pathophysiological relevance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemical synthesis*
  • Antioxidants / pharmacology
  • Cations
  • Chemistry, Pharmaceutical / methods*
  • Drug Design
  • Flavonoids / chemistry
  • Mitochondria / metabolism*
  • Mitochondria, Liver / metabolism
  • Oxidants / chemistry
  • Oxidation-Reduction
  • Phenols / chemistry
  • Polyphenols
  • Rats
  • Reactive Oxygen Species
  • Resveratrol
  • Solubility
  • Stilbenes / chemical synthesis*
  • Stilbenes / pharmacology
  • Water / chemistry

Substances

  • Antioxidants
  • Cations
  • Flavonoids
  • Oxidants
  • Phenols
  • Polyphenols
  • Reactive Oxygen Species
  • Stilbenes
  • Water
  • Resveratrol